NAS:PBAXW (USA)
Â
Warrants (01/09/2026)
$
0.05
-0.0199 (-28.43%)
03:57 PM EST
Business Description
Phoenix Biotech Acquisition Corp
NAICS : 551112
SIC : 6719
Share Class Description:
PBAXW: Warrants (01/09/2026)Description
Phoenix Biotech Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company intends to pursue an acquisition opportunity in any business, industry, sector or geographical location, industries that complement management team's background, and to capitalize on the ability of management team to identify and acquire a business in the healthcare or healthcare related industries in the United States and Europe.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.09 | |||||
| Equity-to-Asset | -0.65 | |||||
| Debt-to-Equity | -0.26 | |||||
| Debt-to-EBITDA | -0.36 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.76 | |||||
| Quick Ratio | 1.76 | |||||
| Cash Ratio | 0.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -7.41 | |||||
| ROA % | -4.84 | |||||
| ROIC % | -10.3 | |||||
| ROC (Joel Greenblatt) % | -39.38 | |||||
| ROCE % | -8.93 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -9.8 | |||||
| EV-to-EBITDA | -9.8 | |||||
| EV-to-FCF | -22.07 | |||||
| Earnings Yield (Greenblatt) % | -10.2 | |||||
| FCF Yield % | -4.69 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PBAXW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Phoenix Biotech Acquisition Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0 - 0.58 | ||
| Shares Outstanding (Mil) |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Phoenix Biotech Acquisition Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Phoenix Biotech Acquisition Corp Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Phoenix Biotech Acquisition Corp Frequently Asked Questions
What is Phoenix Biotech Acquisition Corp(PBAXW)'s stock price today?
The current price of PBAXW is $0.05. The 52 week high of PBAXW is $0.58 and 52 week low is $0.00.
When is next earnings date of Phoenix Biotech Acquisition Corp(PBAXW)?
The next earnings date of Phoenix Biotech Acquisition Corp(PBAXW) is 2024-11-08 Est..
Does Phoenix Biotech Acquisition Corp(PBAXW) pay dividends? If so, how much?
Phoenix Biotech Acquisition Corp(PBAXW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers